A citation-based method for searching scientific literature

Megan L Hutchcraft, Holly H Gallion, Jill M Kolesar. Diagnostics (Basel) 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Contribution of MUTYH Variants to Male Breast Cancer Risk: Results From a Multicenter Study in Italy.
Piera Rizzolo, Valentina Silvestri, Agostino Bucalo, Veronica Zelli, Virginia Valentini, Irene Catucci, Ines Zanna, Giovanna Masala, Simonetta Bianchi, Alessandro Mauro Spinelli,[...]. Front Oncol 2018
14
100

Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?
Antonio Russo, Valentina Calò, Loredana Bruno, Valentina Schirò, Valentina Agnese, Sandra Cascio, Elena Foddai, Daniele Fanale, Sergio Rizzo, Francesca Di Gaudio,[...]. Breast Cancer Res Treat 2009
15
100

Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.
Emanuele Mazzola, Amanda Blackford, Giovanni Parmigiani, Swati Biswas. Cancer Inform 2015
19
100

Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature?
Sara Di Lorenzo, Daniele Fanale, Bartolo Corradino, Valentina Caló, Gaetana Rinaldi, Viviana Bazan, Antonio Giordano, Adriana Cordova, Antonio Russo. Cancer Biol Ther 2016
9
100

Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines.
Cynthia L Neben, Anjali D Zimmer, Will Stedden, Jeroen van den Akker, Robert O'Connor, Raymond C Chan, Elaine Chen, Zheng Tan, Annette Leon, Jack Ji,[...]. J Mol Diagn 2019
32
100

Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer.
Marijke Wasielewski, Astrid A Out, Joyce Vermeulen, Maartje Nielsen, Ans van den Ouweland, Carli M J Tops, Juul T Wijnen, Hans F A Vasen, Marjan M Weiss, Jan G M Klijn,[...]. Breast Cancer Res Treat 2010
27
100

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
542
100

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
252
100

The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.
Marketa Janatova, Zdenek Kleibl, Jana Stribrna, Ales Panczak, Kamila Vesela, Martina Zimovjanova, Petra Kleiblova, Pavel Dundr, Jana Soukupova, Petr Pohlreich. Cancer Epidemiol Biomarkers Prev 2013
32
100

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Mary B Daly, Robert Pilarski, Matthew B Yurgelun, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Judy E Garber,[...]. J Natl Compr Canc Netw 2020
93
100

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.
Stefania Gori, Massimo Barberis, Maria Angela Bella, Fiamma Buttitta, Ettore Capoluongo, Paola Carrera, Nicoletta Colombo, Laura Cortesi, Maurizio Genuardi, Massimo Gion,[...]. Crit Rev Oncol Hematol 2019
27
100

Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).
Fatima Zahra El Ansari, Farah Jouali, Nabila Marchoudi, Mohcine Mechita Bennani, Naima Nourouti Ghailani, Amina Barakat, Jamal Fekkak. BMC Cancer 2020
1
100

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
303
100

Frequency of the CHEK2 1100delC mutation among women with early-onset and bilateral breast cancer.
Dapeng Ding, Ying Zhang, Xiaofeng He, Wei Meng, Wenli Ma, Wenling Zheng. Breast Cancer Res 2012
5
100

Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
N Stjepanovic, L Moreira, F Carneiro, F Balaguer, A Cervantes, J Balmaña, E Martinelli. Ann Oncol 2019
30
100

Hereditary breast and ovarian cancer: new genes in confined pathways.
Finn Cilius Nielsen, Thomas van Overeem Hansen, Claus Storgaard Sørensen. Nat Rev Cancer 2016
175
100

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Georgios N Tsaousis, Eirini Papadopoulou, Angela Apessos, Konstantinos Agiannitopoulos, Georgia Pepe, Stavroula Kampouri, Nikolaos Diamantopoulos, Theofanis Floros, Rodoniki Iosifidou, Ourania Katopodi,[...]. BMC Cancer 2019
20
100

BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype-phenotype correlation in a cohort of 531 patients.
Lorena Incorvaia, Daniele Fanale, Marco Bono, Valentina Calò, Alessia Fiorino, Chiara Brando, Lidia Rita Corsini, Sofia Cutaia, Daniela Cancelliere, Alessia Pivetti,[...]. Ther Adv Med Oncol 2020
4
100

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
C J van Asperen, R M Brohet, E J Meijers-Heijboer, N Hoogerbrugge, S Verhoef, H F A Vasen, M G E M Ausems, F H Menko, E B Gomez Garcia, J G M Klijn,[...]. J Med Genet 2005
259
100

Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
Kari G Chaffee, Ann L Oberg, Robert R McWilliams, Neil Majithia, Brian A Allen, John Kidd, Nanda Singh, Anne-Renee Hartman, Richard J Wenstrup, Gloria M Petersen. Genet Med 2018
52
100

Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy.
Beth Dudley, Eve Karloski, Federico A Monzon, Aatur D Singhi, Stephen E Lincoln, Nathan Bahary, Randall E Brand. Cancer 2018
10
100

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
21
100

BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
David B Zhen, Kari G Rabe, Steven Gallinger, Sapna Syngal, Ann G Schwartz, Michael G Goggins, Ralph H Hruban, Michele L Cote, Robert R McWilliams, Nicholas J Roberts,[...]. Genet Med 2015
134
100

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
488
100

Beyond BRCA1 and BRCA2: Deleterious Variants in DNA Repair Pathway Genes in Italian Families with Breast/Ovarian and Pancreatic Cancers.
Aldo Germani, Simona Petrucci, Laura De Marchis, Fabio Libi, Camilla Savio, Claudio Amanti, Adriana Bonifacino, Barbara Campanella, Carlo Capalbo, Augusto Lombardi,[...]. J Clin Med 2020
1
100

MutYH mutation carriers have increased breast cancer risk.
Gad Rennert, Flavio Lejbkowicz, Ilana Cohen, Mila Pinchev, Hedy S Rennert, Ofra Barnett-Griness. Cancer 2012
37
100

Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)-Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes.
Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, Marco Bono, Valentina Calò, Daniela Cancelliere, Marta Castiglia, Alessia Fiorino, Alessia Pivetti, Nadia Barraco,[...]. Cancers (Basel) 2020
6
100

A novel nonsense mutation in the EpCAM gene in a patient with congenital tufting enteropathy.
Cornelia Thoeni, Achiya Amir, Conghui Guo, S Zhang, Yaron Avitzur, Y M Heng, Ernest Cutz, Aleixo M Muise. J Pediatr Gastroenterol Nutr 2014
14
100

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.
Holly LaDuca, A J Stuenkel, Jill S Dolinsky, Steven Keiles, Stephany Tandy, Tina Pesaran, Elaine Chen, Chia-Ling Gau, Erika Palmaer, Kamelia Shoaepour,[...]. Genet Med 2014
208
100

Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status.
Payal D Shah, Sujata Patil, Maura N Dickler, Kenneth Offit, Clifford A Hudis, Mark E Robson. Cancer 2016
21
100


Multigene panel testing results in patients with multiple breast cancer primaries.
Jessica Corredor, Ashley H Woodson, Angelica Gutierrez Barrera, Banu Arun. Breast J 2020
4
100

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
Jacqueline Mersch, Michelle A Jackson, Minjeong Park, Denise Nebgen, Susan K Peterson, Claire Singletary, Banu K Arun, Jennifer K Litton. Cancer 2015
248
100

Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes.
Chunling Hu, Holly LaDuca, Hermela Shimelis, Eric C Polley, Jenna Lilyquist, Steven N Hart, Jie Na, Abigail Thomas, Kun Y Lee, Brigette Tippin Davis,[...]. JCO Precis Oncol 2018
17
100

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
197
100

Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.
Aung Ko Win, Jeanette C Reece, James G Dowty, Daniel D Buchanan, Mark Clendenning, Christophe Rosty, Melissa C Southey, Joanne P Young, Sean P Cleary, Hyeja Kim,[...]. Int J Cancer 2016
48
100

Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test.
Hee-Chul Shin, Han-Byoel Lee, Tae-Kyung Yoo, Eun-Shin Lee, Ryong Nam Kim, Boyoung Park, Kyong-Ah Yoon, Charny Park, Eun Sook Lee, Hyeong-Gon Moon,[...]. Cancer Res Treat 2020
7
100

Risk of pancreatic cancer in breast cancer families from the breast cancer family registry.
Evelina Mocci, Roger L Milne, Elena Yuste Méndez-Villamil, John L Hopper, Esther M John, Irene L Andrulis, Wendy K Chung, Mary Daly, Saundra S Buys, Nuria Malats,[...]. Cancer Epidemiol Biomarkers Prev 2013
46
100

Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.
Jennifer L Beebe-Dimmer, Ashley L Kapron, Alison M Fraser, Ken R Smith, Kathleen A Cooney. J Clin Oncol 2020
8
100

HGVS Recommendations for the Description of Sequence Variants: 2016 Update.
Johan T den Dunnen, Raymond Dalgleish, Donna R Maglott, Reece K Hart, Marc S Greenblatt, Jean McGowan-Jordan, Anne-Francoise Roux, Timothy Smith, Stylianos E Antonarakis, Peter E M Taschner. Hum Mutat 2016
613
100

Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome.
Daniele Fanale, Alessia Fiorino, Lorena Incorvaia, Alessandra Dimino, Clarissa Filorizzo, Marco Bono, Daniela Cancelliere, Valentina Calò, Chiara Brando, Lidia Rita Corsini,[...]. Front Oncol 2021
1
100

Multi-gene Panel Testing in Breast Cancer Management.
Christos Fountzilas, Virginia G Kaklamani. Cancer Treat Res 2018
7
100

CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer.
Maren Weischer, Børge G Nordestgaard, Paul Pharoah, Manjeet K Bolla, Heli Nevanlinna, Laura J Van't Veer, Montserrat Garcia-Closas, John L Hopper, Per Hall, Irene L Andrulis,[...]. J Clin Oncol 2012
103
100

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.
Beth Crawford, Sophie B Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van 't Veer. Breast Cancer Res Treat 2017
47
100

Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.
Daniele Fanale, Lorena Incorvaia, Clarissa Filorizzo, Marco Bono, Alessia Fiorino, Valentina Calò, Chiara Brando, Lidia Rita Corsini, Nadia Barraco, Giuseppe Badalamenti,[...]. Cancers (Basel) 2020
6
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.